Chasing Compliance, presented by Global Regulatory Writing & Consulting, is a podcast focused on regulatory strategy, achieving and maintaining regulatory compliance, and the influence of regulation on healthcare overall. Guests include highly accomplished regulatory professionals, medical writers, scientists, engineers, and clinicians giving their take on some of the most complicated and challenging topics in clinical development.
All content for Chasing Compliance: The Global Regulatory Podcast is the property of GLOBAL and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Chasing Compliance, presented by Global Regulatory Writing & Consulting, is a podcast focused on regulatory strategy, achieving and maintaining regulatory compliance, and the influence of regulation on healthcare overall. Guests include highly accomplished regulatory professionals, medical writers, scientists, engineers, and clinicians giving their take on some of the most complicated and challenging topics in clinical development.
Welcome to Chasing Compliance, the Global Regulatory Writing and Consulting podcast where we discuss all aspects of medical device and pharmaceutical regulatory and clinical strategy from bench to bedside. Today we are chatting with Eimile Oakes and Andrew Stephens, discussing Clinical Study Reports, also known as CSRs. CSRs must tell a clear, compliant, and credible story of a clinical trial. With so many moving parts and often tight timelines, getting it right requires expertise. Tune in to hear their advice on how to deliver these documents with accuracy and efficiency!
Chasing Compliance: The Global Regulatory Podcast
Chasing Compliance, presented by Global Regulatory Writing & Consulting, is a podcast focused on regulatory strategy, achieving and maintaining regulatory compliance, and the influence of regulation on healthcare overall. Guests include highly accomplished regulatory professionals, medical writers, scientists, engineers, and clinicians giving their take on some of the most complicated and challenging topics in clinical development.
